Skip to content

Supplier News

AstraZeneca buys Takeda respiratory business

AstraZeneca buys Takeda respiratory business

AstraZeneca plans to acquire the core respiratory business of Takeda Pharmaceutical Co. Ltd. for $575 million. Under the agreement, approximately 200 Takeda staff will transfer to AstraZeneca after the closing of the transaction, expected in the first quarter of 2016.

Sucampo CEO to become chairman

Sucampo CEO to become chairman

Peter Greenleaf, chief executive officer of Sucampo Pharmaceuticals Inc., has been appointed as chairman of the board. Sucampo said late Tuesday that Greenleaf, the company’s CEO and a board member since March 2014, is slated to take the reins as chairman on Jan. 1.

General Mills makes strides in reducing sodium

General Mills makes strides in reducing sodium

General Mills reports that it’s making headway in its effort sodium by 20% across 10 key U.S. retail product categories by the end of this year. The food company said Tuesday that it has met or exceeded its goal in seven of 10 categories, with reductions across the 10 categories ranging from 18%

Sanofi, Boehringer Ingelheim mull business swap

Sanofi, Boehringer Ingelheim mull business swap

Sanofi and Boehringer Ingelheim are in talks to swap their animal health and consumer health care businesses, respectively. The companies said Tuesday that the proposed transaction would involve an exchange of Sanofi’s Merial animal health business (“Merial”), valued at €11.4 billion ($12.

Hershey tabs Coke exec as global sales chief

Hershey tabs Coke exec as global sales chief

The Hershey Co. has hired sales veteran Rob Gehring as global chief sales officer. Hershey said Gehring is slated to assume the post effective Jan. 18. He comes to the company from Coca-Cola North America, where he served as president of the Walmart global team since 2011.

Allergan rolls out IBS drug Viberzi

Allergan rolls out IBS drug Viberzi

Allergan plc has released Viberzi (eluxadoline), a treatment for irritable bowel syndrome with diarrhea (IBS-D), to U.S. pharmacies. The company said Monday that Viberzi, a twice-daily oral medication, relieves the core symptoms of IBS-D: recurrent diarrhea and abdominal pain.

Endo granted extended U.S. rights for Voltaren Gel

Endo granted extended U.S. rights for Voltaren Gel

Endo International plc has received an extension of its exclusive U.S. marketing rights for Voltaren Gel (diclofenac sodium topical gel 1%), a nonsteriodal anti-inflammatory drug (NSAID). Endo said Monday that it also was granted extended U.S.

Newell Rubbermaid Acquires Jarden

Newell Rubbermaid Acquires Jarden

Newell Rubbermaid Inc. is buying Jarden Corp. for about $13.2 billion in cash and stock, combining brands including Paper Mate, Sunbeam and Yankee Candle. Jarden shareholders will receive, per share, $21 and 0.862 shares of Newell Rubbermaid stock at closing.

Horizon adds gout drug with Crealta acquisition

Horizon adds gout drug with Crealta acquisition

Horizon Pharma plc plans to acquire Crealta Holdings LLC for $510 million in cash. Horizon said the deal will bring the company Krystexxa (pegloticase), the first and only Food and Drug Administration-approved drug for chronic refractory gout.

Takeda’s Ninlaro becomes available in U.S.

Takeda’s Ninlaro becomes available in U.S.

Takeda Pharmaceutical Co. has released Ninlaro capsules (ixazomib), a blood cancer medication, in the United States. Takeda said Friday that Ninlaro is the first and only oral proteasome inhibitor.

Jelly Belly to expand Star Wars lineup

Jelly Belly to expand Star Wars lineup

Jelly Belly Candy Co. has a way for the Force to be with retailers. For the debut of the major motion picture “Star Wars: The Force Awakens” on Dec. 18, the candy maker next month plans to release two new products for its Star Wars Collection of gifts: the 8.5-oz. “Star Wars: The Force Awakens”

Amneal starts rollout of lidocaine product line

Amneal starts rollout of lidocaine product line

Amneal Pharmaceuticals LLC has begun shipping lidocaine 5% ointment to lead off the launch of a new lidocaine product line. Amneal said late Tuesday that its lidocaine 5% ointment is available in a 35.44-g tube with child-resistant cap and in a 50-g jar.

Camber launches generic version of Prozac

Camber launches generic version of Prozac

Camber Pharmaceuticals has released fluoxetine capsules, an antidepressant, and losartan potassium, a hypertension medication. Camber said Tuesday that its fluoxetine capsules are available in strengths of 10 mg, 20 mg, 40 mg in both 30 and 100-count bottles.

Schweppes rolls out dark ginger ale

Schweppes rolls out dark ginger ale

With the onset of the holiday season, Schweppes has introduced the new Schweppes Dark Ginger Ale to give consumers more ginger taste. The Dr. Pepper Snapple Group brand said Monday that Schweppes Dark Ginger Ale taps into the rising demand for stronger flavors.

EcoTools unveils holiday brush sets

EcoTools unveils holiday brush sets

EcoTools is featuring three limited-edition holiday makeup brush sets in a new online videos as part of its “Looks You Love” series. The beauty care accessories company said Monday that the video tutorials introduce new makeup and hair looks for the holidays developed by the EcoTools Beauty Team.